Gouda Ayman A, Hashem Hisham, Jira Thomas
Chemistry Department, Faculty of Science, Zagazig University, Zagazig 44519, Egypt; Faculty of Public Health and Informatics, Umm AL-Qura University, Makkah, Saudi Arabia.
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Jazan University, Saudi Arabia.
Spectrochim Acta A Mol Biomol Spectrosc. 2014 Sep 15;130:480-7. doi: 10.1016/j.saa.2014.04.015. Epub 2014 Apr 18.
Simple, rapid and accurate high performance liquid chromatographic (HPLC) and spectrophotometric methods are described for determination of antihistaminic acrivastine in capsules. The first method (method A) is based on accurate, sensitive and stability indicating chromatographic separation method. Chromolith® Performance RP-18e column, a relatively new packing material consisting of monolithic rods of highly porous silica, was used as stationary phase applying isocratic binary mobile phase of ACN and 25 mM NaH2PO4 pH 4.0 in the ratio of 22.5:77.5 at flow rate of 5.0 mL/min and 40°C. A diode array detector was used at 254 nm for detection. The elution time of acrivastine was found to be 2.080±0.032. The second and third methods (methods B and C) are based on the oxidation of acrivastine with excess N-bromosuccinimide (NBS) and determination of the unconsumed NBS with, metol-sulphanilic acid (λmax: 520 nm) or amaranth dye (λmax: 530 nm). The reacted oxidant corresponds to the drug content. Beer's law is obeyed over the concentration range 1.563-50, 2.0-20 and 1.0-10 μg mL(-1) for methods A, B and C, respectively. The limits of detection and quantitation were 0.40, 0.292 and 0.113 μg mL(-1) and 0.782, 0.973 and 0.376 μg mL(-1) for methods A, B and C, respectively. The HPLC method was validated for system suitability, linearity, precision, limits of detection and quantitation, specificity, stability and robustness. Stability tests were done through exposure of the analyte solution for four different stress conditions and the results indicate no interference of degradants with HPLC-method. The proposed methods was favorably applied for determination of acrivastine in capsules formulation. Statistical comparison of the obtained results from the analysis of the studied drug to those of the reported method using t- and F-tests showed no significant difference between them.
本文描述了用于测定胶囊中抗组胺药阿伐斯汀的简单、快速且准确的高效液相色谱(HPLC)法和分光光度法。第一种方法(方法A)基于准确、灵敏且具有稳定性指示作用的色谱分离法。采用Chromolith® Performance RP - 18e柱,这是一种由高度多孔硅胶整体柱组成的相对较新的填充材料,作为固定相,以乙腈和25 mM pH 4.0的磷酸二氢钠按22.5:77.5的比例组成等度二元流动相,流速为5.0 mL/min,温度为40°C。使用二极管阵列检测器在254 nm处进行检测。阿伐斯汀的洗脱时间为2.080±0.032。第二种和第三种方法(方法B和方法C)基于阿伐斯汀与过量N - 溴代琥珀酰亚胺(NBS)的氧化反应,并用米吐尔 - 磺胺酸(λmax:520 nm)或苋菜红染料(λmax:530 nm)测定未消耗的NBS。反应后的氧化剂与药物含量相对应。方法A、B和C分别在1.563 - 50、2.0 - 20和1.0 - 10 μg mL⁻¹的浓度范围内符合比尔定律。方法A、B和C的检测限和定量限分别为0.40、0.292和0.113 μg mL⁻¹以及0.782、0.973和0.376 μg mL⁻¹。对HPLC法进行了系统适用性、线性、精密度、检测限和定量限、特异性、稳定性及稳健性的验证。通过将分析物溶液暴露于四种不同的应激条件下进行稳定性测试,结果表明降解产物对HPLC法无干扰。所提出的方法成功应用于胶囊制剂中阿伐斯汀的测定。使用t检验和F检验对所研究药物分析获得的结果与报道方法的结果进行统计比较,结果表明两者之间无显著差异。